Acetylation in hormone signaling and the cell cycle

Cytokine and Growth Factor Reviews

Volumn 13, Issue 3, 2002, Pages 259-276

  Fu, Maofu ^a   Wang, Chenguang ^a   Wang, Jian ^a   Zafonte, Brian T ^a   Lisanti, Michael P ^a,b   Pestell, Richard G ^a  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cyclin dependent kinases; Histone acetyltransferases

Indexed keywords

CARRIER PROTEIN; CYCLIN DEPENDENT KINASE; CYCLINE; HISTONE; HISTONE ACETYLTRANSFERASE; HORMONE; STRUCTURAL PROTEIN; TRANSCRIPTION FACTOR; HISTONE DEACETYLASE; LIGAND;

ACETYLATION; CELL CYCLE; CELL FUNCTION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONE ACTION; HUMAN; MOLECULAR CLONING; MOLECULAR INTERACTION; NONHUMAN; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CHROMATIN; METABOLISM; METHYLATION; PHOSPHORYLATION;

ACETYLATION; ANIMAL; CELL CYCLE; CHROMATIN; CLONING, MOLECULAR; HISTONE DEACETYLASES; HORMONES; HUMAN; LIGANDS; METHYLATION; MODELS, BIOLOGICAL; MODELS, GENETIC; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS;

EID: 0035992509     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(02)00003-5     Document Type: Review

References (221)

1. Co-factor dynamics and sufficiency in estrogen receptor-regulated transcription
2. Histone acetylase and deacetylases in cell proliferation
3. Retinoblastoma protein recruits histone deacetylase to repress transcription
4. Rb interacts with histone deacetylase to repress transcription
5. Acetylation control of the retinoblastoma tumor-suppressor protein
6. Regulation of E2F1 activity by acetylation
7. hSWI/SNF disrupts interactions between the H2A N-terminal tail and nucleosomal DNA
8. Global role for chromatin remodelling enzymes in mitotic gene expression
9. Regulation of chromatin structure by site-specific histone H3 methyltransferase
10. Role of covalent modifications of histones in regulating gene expression
11. Histone methylation versus histone acetylation: New insights into epigenetic regulation
12. Studies of the DNA binding properties of histone H4 amino terminus: Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 'tail' to DNA
13. Histone acetylation reduces nucleosome core particle linking number change
14. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro
15. A positive role for histone acetylation in transcription factor access to nucleosomal DNA
16. Histone acetylation and the cell cycle in cancer
17. Structure and ligand of a histone acetyltransferase bromodomain
18. Kinase activity and phospohorylaion of the largest subunit of TFIIF transcription factor
19. II250 double bromodomain module
20. p300-mediated acetylation facilitates the transfer of histone H2A-H2B dimers from nucleosomes to a histone chaperone
21. The CBP co-activator is a histone acetyltransferase
22. The transcriptional co-activators p300 and CBP are histone acetyltransferases
23. Histone deacetylase: A regulator of transcription
24. Histone acetylation and transcriptional regulatory mechanisms
25. Nuclear receptor co-regulators: Cellular and molecular biology
26. A transcriptional co-repressor that interacts with nuclear hormone receptors
27. Ligand-independent repression by the thyroid hormone receptor mediated by nuclear receptor co-repressor
28. Unique forms of human and mouse nuclear receptor co-repressor SMRT
29. SMRTe, a silencing mediator for retinoid and thyroid hormone receptor-extended isoform that is more related to the nuclear receptor co-repressor
30. Alien, a highly conserved protein with characteristics of a co-repressor for members of the nuclear hormone receptor superfamily
31. Co-repressors 2000
32. Structure and specificity of nuclear receptor-co-activator interactions
33. Hormone-dependent co-activator binding to a hydrophobic cleft on nuclear receptors
34. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
35. The structural basis of estrogen receptor/co-activator recognition and the antagonism of this interaction by tamoxifen
36. The receptor-associated co-activator 3 activates transcription through CREB-binding protein recruitment and autoregulation
37. The SRC family of nuclear receptor co-activators
38. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
39. Sequence and characterization of a co-activator for the steroid hormone receptor superfamily
40. Co-activators and co-repressors in the integration of transcriptional responses
41. The co-activator TIF2 contains three nuclear receptor binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
42. Nuclear receptor-binding sites of co-activators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor co-activator 1 (SRC-1): Multiple motifs with different binding specificities
43. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both co-repressors and co-activators
44. Ligand-independent recruitment of steroid receptor co-activators to estrogen receptor by cyclin D1
45. CBP/p300 in cell growth, transformation and development
46. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2
47. A possible involvement of TIF1α and TIF1β in the epigenetic control of transcription by nuclear receptors
48. The Angelman syndrome-associated protein, E6-AP, is a co-activator for the nuclear hormone receptor superfamily
49. Proteasome-dependent degradation of the human estrogen receptor
50. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase
51. A cold-inducible co-activator of nuclear receptors linked to adaptive thermogenesis
52. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells
53. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p
54. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription
55. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
56. Histone deacetylase associated with the Sin3 co-repressor mediate Mad transcriptional repression
57. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor
58. Characterization of a human RPD3 ortholog, HDAC3
59. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional co-repressor
60. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression
61. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression
62. Three proteins define a class of human histone deacetylases related to yeast Hda1p
63. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
64. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3
65. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
66. dMi-2, a hunchback-interacting protein that functions in polycomb repression
67. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis co-fractionates with an associated Snf2 superfamily ATPase
68. HDAC4 deacetylase associates with and represses the MEF2 transcription factor
69. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
70. Viral Ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion
71. A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors
72. Cloning and characterization of a co-repressor and potential component of the nuclear hormone receptor repression complex
73. Inhibition of estrogen receptor activity by a BRCA1-ER-α interaction
74. BRCA1 inhibition of estrogen receptor signaling in transfected cells
75. NuRD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities
76. PSF is a novel co-repressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors
77. Sinful repression
78. Histone deacetylases: Transcriptional repression with SINers and NuRDs
79. Histone deacetylase activity is required for full transcriptional repression by mSin3A
80. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase
81. Stoichiometric and steric principles governing repression by nuclear hormone receptors
82. Nuclear receptor DAX-1 recruits nuclear receptor co-repressor N-CoR to steroidogenic factor 1
83. Proteasomal regulation of nuclear receptor co-repressor-mediated repression
84. BRCA1 interacts with components of the histone deacetylase complex
85. Direct acetylation of the estrogen receptor-α hinge region by p300 regulates transactivation and hormone sensitivity
86. Disruption of BRCA1 LXCXE alters BRCA1 functional activity and regulation of Rb family but not Rb protein binding
87. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
88. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) co-repressor
89. The SMRT co-repressor is regulated by a MEK-1 kinase pathway: Inhibition of co-repressor function is associated with SMRT phosphorylation and nuclear export
90. Differential localization of HDAC4 orchestrates muscle differentiation
91. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
92. Transforming growth factor β1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivo
93. A Smad transcriptional co-repressor
94. Acetylation of histones and transcription-related factors
95. Histone-like TAFs within the PCAF histone acetylase complex
96. The 400 kDa subunit of the P/CAF histone acetylase complex belongs to the ATM superfamily
97. The novel ATM-related protein TRRAP is an essential co-factor for the c-Myc and E2F oncoproteins
98. Critical residues for histone acetylation by GCN5, functioning in Ada and SAGA complexes are also required for transcriptional function in vivo
99. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
100. p300 and P/CAF acetylate the androgen receptor at sites governing hormone-dependent transactivation
101. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9
102. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis
103. HIV Tat transcriptional activity is regulated by acetylation
104. NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esalp and the ATM-related co-factor Tra1p
105. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation
106. Steroid receptor co-activator-1 is a histone acetyltransferase
107. Nuclear receptor co-activator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
108. II250 subunit of TFIID has histone acetyltransterase activity
109. A growing co-activator network
110. The acetyltransterase activity of CBP stimulates transcription
111. Expanded lysine acetylation specificity of GCN5 in native complexes
112. Transcription factor-specific requirements for co-activators and their acetyltransferase functions
113. What's up and down with histone deacetylation and transcription?
114. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage
115. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases
116. CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites
117. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase
118. Gene activation by histone and factor acetyltransferases
119. Chromatin and chromosomal controls in development
120. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and re-initiation
121. Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates
122. p300 forms a stable, template-committed complex with chromatin: Role for the bromodomain
123. A hypersensitive estrogen receptor-α mutation in premalignant breast lesions
124. Phosphorylation of steroid receptor co-activator-1: Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway
125. Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells
126. Functional interactions within adenovirus E1A protein complexes
127. CREB-binding protein activates transcription through multiple domains
128. Stimulation of p300-mediated transcription by the kinase MEKK1
129. AIB1 Is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
130. Acetylation sites govern PKA-dependent androgen receptor function
131. The proteins of chromatin. Part I. Histones
132. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena
133. Methylation of histone H3 lysine 9 creates a binding pocket for HP1 proteins
134. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromodomain
135. Role of histone H3 lysine 9 methylation in heterochromatin assembly and epigenetic gene silencing
136. Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31
137. Isolation and characterization of suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression
138. DNA methyltransferases DNMT3a DNMT3b are essential for de novo methylation and mammalian development
139. Protein arginine methyltransferase I, the predominant protein arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3
140. PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells
141. Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor co-activator PRMT1
142. Regulation of transcription by a protein methyltransferase
143. Synergistic enhancement of nuclear receptor function by p160 co-activators and two co-activators with protein methyltransferase activities
144. Relationship between methylation and acetylation of arginine-rich histones in cycling and arrested HeLa cells
145. Acetylation and methylation of histones H3 and H4 in chicken immature erythrocytes are not directly coupled
146. Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors
147. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation
148. Signaling to chromatin through histone modification
149. Dynamically acetylated histones of chicken erythrocytes are selectively methylated
150. Physical association between the histone acetyltransferase CBP and a histone methyltransferase
151. The language of covalent histone modifications
152. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
153. Demethylase activity is directed by histone acetylation
154. DNA methyltransferase DNMT1 associates with histone deacetylase activity
155. DNMT3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription
156. The cell cycle in steroid hormone regulated proliferation and differentiation
157. Rb targets histone H3 methylation and HP1 to promoters
158. MAP kinase-mediated signalling to nucleosomes and immediate early gene induction
159. Increased Set-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts
160. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3
161. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
162. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
163. 2 and spreads in an ordered fashion coincident with mitotic chromosome condensation
164. Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation
165. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation
166. Mitotic phosphorylation of histone H3 is governed by Ip11/aurora kinase and Glc7/P1 phosphatase in budding yeast and nematodes
167. Mitotic histone H3 phosphorylation by the NIMA kinase in Aspergillus nidulans
168. Kinetics of histone methylation in vivo and its relation to the cell cycle in Ehrlich ascites tumor cells
169. The periodic synthesis of S-adenosyhnethionine: Protein methyltransferases during the HeLa S-3 cell cycle
170. The methylation of histones during regeneration of the liver
171. Methylation of lysine residues of histone fractions in synchronized mammalian cells
172. Studies of histone methylation during the HeLa S-3 cell cycle
173. In vivo methylation and turnover of rat brain histones
174. Cancer cell cycles
175. Control of eukaryotic cell cycle progression by phosphorylation of cyclin-dependent kinases
176. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation
177. Cell cycle dysregulation in breast cancer: Breast cancer therapies targeting the cell cycle
178. Where the cell cycle and histone meet
179. Sin meets NuRD and other tails of repression
180. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor
181. The essential co-factor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
182. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis
183. Cell cycle-regulated phosphorylation of p220 NPAT by cyclin E-Cdk2 in cajal bodies promotes histone gene transcription
184. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription
185. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis
186. 1
187. 1 phase in rodent fibroblasts
188. 1/S phase transition by expression of cyclins D1 and E with an inducible system
189. 1 to complete the cell cycle
190. Cyclin D1 is required for S-phase traversal in bovine tracheal myocytes
191. 1 checkpoint
192. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway
193. v-src signaling in breast cancer cells
194. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
195. Integration of Rac-dependent regulation of cyclin D1 transcription through an NF-κB-dependent pathway
196. Induction of cyclin D1 by simian virus 40 small tumor antigen
197. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
198. Cyclin E associates with BAF155 and BRG1, components of mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest
199. CDK-independent activation of estrogen receptor by cyclin D1
200. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of Cdk4
201. II250 to regulate Sp1-mediated transcription
202. Cyclin D1 governs androgen receptor function by ligand-dependent regulation of P/CAF
203. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
204. Normal stoichiometry of histone dimer sets is necessary for high fidelity of mitotic chromosome transmission
205. Expression of NPAT, a novel substrate of cyclin E-Cdk2, promotes S-phase entry
206. Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes
207. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 co-activator
208. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A
209. Cdc25A is a novel phosphatase functioning early in the cell cycle
210. Cdk inhibitors: Positive and negative regulators of G1-phase progression
211. Inhibition of cyclin-dependent kinases by p21
212. Radiation-induced cell cycle arrest compromised by p21 deficiency
213. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin
214. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
215. Structure and function of histone acetyltranferases
216. Histone acetylation and disease
217. Functional analysis of the chromodomain of HP
218. The HP1 protein family: Getting a grip on chromatin
219. Histone H2B phosphorylation in mammalian apoptotic cells: An association with DNA fragmentation
220. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139
221. CREB-binding protein and p300 in transcriptional regulation